APTO Aptose Biosciences Inc.
Healthcare$1.71+0.00%ClosedMarket Cap: $4.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.13
P/S
0.00
EV/EBITDA
0.64
DCF Value
$3.22
FCF Yield
0.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-23.2%
ROA
51.7%
ROIC
-1252.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $0.00 | $0.00 | $— | — |
| Q4 null | $0.00 | NaN% | $5.5M | $12.6M | $— | — |
| FY null | $0.00 | NaN% | $0.00 | $0.00 | $— | — |
| Q3 null | $0.00 | NaN% | $0.00 | $0.00 | $— | — |
| Q2 null | $0.00 | NaN% | $0.00 | $-7.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-5.5M | $-5.5M | $— | — |
| Q4 null | $453.0K | 50.0% | $24.1M | $-1.6M | $— | — |
| FY null | $0.00 | NaN% | $0.00 | $-25.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-7.0M | $-7.0M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-7.3M | $-7.3M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-9.8M | $-9.6M | $— | — |
| Q4 2023 | $955.3K | 62.7% | $-12.1M | $-12.0M | $-6.32 | — |